Implant Brand · 4 of 6
Polytech implants
German manufacturer specialising in polyurethane-coated breast implants — the dominant polyurethane producer globally. Strong European market presence. Best for capsular contracture revision and anatomical rotation-critical cases.
Brand-neutral information. This page provides factual reference information about this implant manufacturer — products, technology, regulatory status, market position. It does not endorse this brand over alternatives. The right implant brand for you depends on your specific anatomy, surgical priorities, and your surgeon's recommendation. This practice carries multiple brands; selection is based on anatomic fit and patient priorities, not commercial relationships.
Cross-brand reference
Compare with other brands
See how this brand's profile names, volume increments, and product lines compare to Mentor, Motiva, Polytech, Allergan, Sebbin, and Nagor side-by-side. Translation grid + brand-by-brand catalog breakdown.
View the catalog decoder →
Brand summary
Polytech is a German implant manufacturer with European market dominance, particularly in polyurethane-coated implants — the only manufacturer producing polyurethane-coated implants at scale globally. CE mark in Europe; approved in UK, Australia, Canada, and most international markets. NOT FDA-approved in USA. Best fits: anatomical implants where rotation must be minimised, revision after capsular contracture, complex revision needing strong tissue fixation. Also offers standard textured and smooth lines.
Company overview
| Item | Detail |
|---|
| Company name | POLYTECH Health & Aesthetics GmbH |
| Founded | 1986 |
| Headquarters | Dieburg, Germany |
| Regulatory status | CE mark (EU), MHRA (UK), TGA (Australia), Health Canada (Canada); NOT FDA-approved (USA) |
| Major markets | Germany, Austria, Switzerland, broader Europe, UK, Turkey, Latin America, Australia |
Product specialties
Polyurethane-coated implants — the flagship
Polytech is the dominant manufacturer of polyurethane-coated breast implants globally. The polyurethane foam coating mechanism:
- Outer foam layer encourages strong tissue ingrowth.
- Tissue adherence essentially eliminates rotation in anatomical shapes.
- Capsular contracture rates approximately 1-2% in long-term data (vs 3-6% with smooth, 2-5% with microtextured).
- Foam dissolves over years, leaving silicone shell with adherent surrounding tissue.
Standard textured and smooth lines
Alongside polyurethane, Polytech also offers:
- POLYtxt microtextured — European-standard microtextured surface.
- Smooth surface — Polytech smooth product variants.
- Standard cohesive gel across multiple cohesion levels.
Distinctive product lines
| Product line | Shape | Surface | Notes |
|---|
| Diagon\Gel 4Two | Anatomical (teardrop) | Polyurethane-coated | Premium anatomical; very low rotation |
| Microthane | Round and anatomical | Polyurethane-coated | Established polyurethane line |
| Mesmo | Round | POLYtxt microtextured | Standard microtextured round |
| Sublime Line | Round and anatomical | Multiple options | Premium product family |
| Smooth round | Round | Smooth | Modern smooth options |
The polyurethane mechanism
Polytech polyurethane-coated implants work through three biological phases:
- Phase 1 (weeks 1-4): implantation; surrounding tissue begins to integrate with the foam coating.
- Phase 2 (months 1-12): tissue ingrowth into foam pores; firm adherence develops; rotation prevented.
- Phase 3 (years 1-3+): polyurethane foam gradually dissolves; tissue remains firmly adherent to underlying silicone shell.
The result is sustained low capsular contracture rates (1-2% over 10 years in published data) and essentially zero rotation in anatomical shapes (<0.5% rotation rate in published data). For specific clinical scenarios (capsular contracture revision, anatomical rotation-critical cases), polyurethane offers measurable advantages over alternative surfaces.
Indications where Polytech excels
| Indication | Polytech polyurethane benefit |
|---|
| Capsular contracture revision | Recurrence rate ~5-10% vs ~25-30% with standard surfaces |
| Anatomical implant rotation-critical case | Rotation rate <0.5% vs 1-3% with microtextured |
| Complex revision needing strong fixation | Stable position even in altered tissue planes |
| Patient with capsular contracture risk factors | Lower contracture rates than other surfaces |
| Reconstruction with rotation-prone anatomy | Polyurethane coating maintains correct orientation |
Polytech warranty
Polytech offers comprehensive warranty coverage:
- Lifetime replacement for confirmed rupture.
- Capsular contracture coverage — Baker grade III/IV with exchange.
- Patient registration program for traceability and warranty management.
When Polytech fits
- Patient with prior capsular contracture seeking revision.
- Patient seeking anatomical implants with maximum rotation immunity.
- Patient in markets where Polytech is well-established — Germany, Austria, Switzerland, broader Europe.
- Patient with surgeon experienced with polyurethane-coated implants.
- Complex revision cases needing strong tissue fixation.
When another brand may be appropriate
- USA patients — Polytech not FDA-approved; Mentor or Allergan/Natrelle required.
- Primary augmentation in patients without rotation or contracture concerns — standard textured or smooth from any major brand sufficient.
- Patient seeking specific technology features not in Polytech line — Motiva for Q Inside, Ergonomix.
- Lower-cost priorities — polyurethane premium may not be justified for routine cases.
Frequently asked questions
What makes Polytech distinctive?
Two main features. (1) Polyurethane-coated implants — Polytech is the dominant manufacturer of polyurethane-coated breast implants globally. The polyurethane foam coating produces very strong tissue adherence, essentially zero rotation in anatomical shapes, and very low capsular contracture rates. (2) European market dominance — Polytech is headquartered in Germany (Dieburg) and has very strong market presence in Germany, Austria, Switzerland, and other European countries. Polytech also offers standard textured and smooth implants alongside the polyurethane specialty.
Is Polytech FDA-approved in the USA?
No — Polytech polyurethane-coated implants are not FDA-approved for use in the USA. Standard textured Polytech implants also do not have FDA approval. USA patients seeking Polytech polyurethane must travel internationally. Polytech is widely available across Europe with CE mark and is approved in many international markets including UK (MHRA), Australia, Canada, Turkey, and most other major markets outside the USA.
How does polyurethane coating work?
The implant has three layers: silicone gel filler, silicone shell, and an outer polyurethane foam coating approximately 1-2 mm thick. After implantation, surrounding tissue grows into the foam over weeks-to-months, creating very firm tissue adhesion. Over years, the polyurethane foam dissolves and is gradually absorbed by the body, leaving the silicone shell with surrounding tissue firmly adherent. The result is effectively zero rotation in anatomical shapes and very low capsular contracture rates. See
polyurethane-coated implants page for the surface category context.
Are Polytech implants safer regarding BIA-ALCL?
Polyurethane-coated implants have very low BIA-ALCL risk in current data — comparable to or lower than microtextured surfaces. The mechanism (polyurethane foam coating) appears to not trigger the chronic immune stimulation associated with elevated BIA-ALCL risk in BIOCELL macrotextured surfaces. Polytech has substantial European long-term data supporting low BIA-ALCL incidence. Polytech polyurethane-coated implants were not subject to the 2019 macrotextured recall.
What is Diagon\Gel and how is it different?
Diagon\Gel is Polytech's anatomical/teardrop product line with optimised gel cohesiveness for shape stability. The 'Diagon' refers to the diagonal vector of the gel formulation that produces the natural breast slope. Available in multiple shapes within the anatomical category (Diagon\Gel 4Two, etc.). Generally combined with polyurethane coating for rotation immunity in anatomical shapes.
Is Polytech a good choice for capsular contracture revision?
Yes — this is one of the strongest indications for polyurethane-coated implants. Patients with prior capsular contracture have ~25-30% recurrence risk with standard implant types in revision. Polyurethane-coated revision reduces this rate to approximately 5-10% in published data — a meaningful improvement. The strong tissue adherence to polyurethane creates a more regular capsule that is less prone to contracture. Many surgeons recommend polyurethane-coated implants specifically for capsular contracture revision cases.
Related references